What is required on a supplementary label when an additional drug is added to an admixture?

When an additional drug is added to an admixture, a supplementary label must include specific information to ensure safety and proper use of the compounded preparation. This includes the drug name and quantity, which is essential for the identification of the drug and its dosage within the admixture. The expiration date is also required, as it indicates how long the admixture is stable and safe to use, helping to prevent the administration of potentially ineffective or unsafe medication. Additionally, the unique identifier of the person adding the drug serves to promote accountability and traceability in the compounding process, which is critical for quality assurance in pharmacy practices.

Collectively, these components on the supplementary label provide comprehensive information that supports both patient safety and regulatory compliance in the preparation of compounded pharmaceuticals. This thorough labeling requirement underscores the significance of clear communication among healthcare providers regarding compounded medications.